Did You Suffer Amputations, Kidney Failure or Ketoacidosis After Invokana?

​

Invokana (canagliflozin), is used in the treatment of type 2 diabetes. Invokana was designed to work with the kidneys to remove excess sugar through urination which in turn lowers blood sugar levels in users.

​

If you took Invokana and experienced complications such as amputations, kidney failure or ketoacidosis, you may wish to explore your legal options.

​

MAY 2017: NEW FDA BLACK BOXED WARNING ABOUT AMPUTATION RISK

​

The Food and Drug and Administration (FDA) issued a black boxed warning, the most serious type of warning the FDA issues, for users of the highly prescribed type 2 diabetes drug, Invokana.

​

After clinical trials were completed, the FDA confirmed that Invokana and Invokamet (canagliflozin) caused an increased risk of leg and foot amputations in patients. Invokamet is similar to Invokana, but it contains metformin, another drug used in the treatment of type 2 diabetes, whereas Invokana only contains canagliflozin.

​

FDA Safety Announcement

​

[ 5-16-2017 ] Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. We are requiring new warnings, including our most prominent Boxed Warning, to be added to the canagliflozin drug labels to describe this risk.

​

Patients taking canagliflozin should notify your health care professionals right away if you develop new pain or tenderness, sores or ulcers, or infections in your legs or feet. Talk to your health care professional if you have questions or concerns. Do not stop taking your diabetes medicine without first talking to your health care professional.

​

Health care professionals should, before starting canagliflozin, consider factors that may predispose patients to the need for amputations. These factors include a history of prior amputation, peripheral vascular disease, neuropathy, and diabetic foot ulcers. Monitor patients receiving canagliflozin for the signs and symptoms described above and discontinue canagliflozin if these complications occur.

Read the full FDA safety announcement.

 

Other Dangerous Conditions Suffered by Some Users of Invokana

​

Invokana, has been implicated in a number of side effects that can result in patient complications, hospitalization, and even death. One of the painful and dangerous conditions caused by Invokana is ketoacidosis – an over production of acids and underproduction of insulin in the blood. This condition can cause diabetic comas which can result in death.

​

Kidney failure is another damaging side effect of Invokana use. When a patient’s kidneys fail, waste and other fluids build up in the body and causes weakness, shortness of breath, lethargy and confusion.

​

Do not ignore the signs. If you are currently taking Invokana and experience any difficulty breathing, hyperventilation, or unusual fatigue, seek immediate medical attention. If you or a loved one was diagnosed with kidney failure or ketoacidosis while taking Invokana, you may wish to explore your legal options by calling 1-800-LAW-FIRM. You may be entitled to a cash settlement for the damage to your health caused by this dangerous drug.

​

In 2013, when Invokana was first approved by the FDA, over 450 patients reported toxic and harmful side effects from the medication. Most of those reports included kidney failure, severe dehydration and urinary tract infections. The FDA has already sounded the alarm on Invokana, warning that its dangerous side effects, including ketoacidosis, can be life threatening if left untreated. The FDA is now questioning whether the benefits of Invokana outweigh its potential risks.

 

Our attorneys are actively accepting cases involving leg and foot amputations, ketoacidosis and kidney failure resulting from the use of Invokana. Do not miss your opportunity to be compensated for your health issues and suffering caused by irresponsible drug manufacturers. Call 1-800-LAW-HELP now for a free, confidential consultation.

​

Invokana Key Points

• Invokana was introduced to the drug market in 2013 as a treatment for Type 2 diabetes

• In May 2015, the FDA warned that the medication has potentially fatal side effects including kidney failure and ketoacidosis. Ketoacidosis is when the body produces too many acids in the blood stream and not enough Insulin

• Ketoacidosis may cause diabetic comas which can result in death

• The FDA has issued a warning urging all patients using Invokana to seek immediate medical treatment if they are suffering from abdominal pain, fatigue or difficulty breathing

• In May 2016, the FDA introduced its first safety warning regarding the connection between Invokana use and amputation risk

• In May 2017, the FDA issued its most severe black boxed warning that was announced after the results of completed clinical trials showed that Invokana users may have a risk that is twice as high as is typical

​

Side Effects & Symptoms

• Difficulty breathing

• Unusual fatigue or tiredness

• Abdominal pain

• Nausea or vomiting